Insider Transactions in Q2 2023 at Revolution Medicines, Inc. (RVMD)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 20
2023
|
Jeff Cislini General Counsel |
SELL
Open market or private sale
|
Direct |
1,239
-2.7%
|
$30,975
$25.14 P/Share
|
|
Jun 20
2023
|
Jack Anders Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,249
-2.22%
|
$29,976
$24.89 P/Share
|
|
Jun 20
2023
|
Margaret A Horn Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,102
-2.07%
|
$50,448
$24.89 P/Share
|
|
Jun 20
2023
|
Stephen Michael Kelsey |
SELL
Open market or private sale
|
Direct |
2,102
-0.64%
|
$50,448
$24.89 P/Share
|
|
Jun 08
2023
|
Sushil Patel |
BUY
Grant, award, or other acquisition
|
Direct |
5,200
+24.88%
|
-
|
|
Jun 08
2023
|
Eric Thomas Schmidt |
BUY
Grant, award, or other acquisition
|
Direct |
5,200
+19.66%
|
-
|
|
Jun 08
2023
|
Elizabeth M Anderson |
BUY
Grant, award, or other acquisition
|
Direct |
5,200
+24.73%
|
-
|
|
Jun 08
2023
|
Barbara Weber |
BUY
Grant, award, or other acquisition
|
Direct |
5,200
+24.73%
|
-
|
|
Jun 08
2023
|
Alexis Borisy |
BUY
Grant, award, or other acquisition
|
Direct |
5,200
+2.12%
|
-
|
|
Jun 08
2023
|
Flavia Borellini |
BUY
Grant, award, or other acquisition
|
Direct |
5,200
+22.77%
|
-
|
|
Jun 08
2023
|
Lorence H. Kim |
BUY
Grant, award, or other acquisition
|
Direct |
5,200
+7.33%
|
-
|